Senior Scientist, Leidos Biomedical Research, Inc.
Center for Cancer Research
National Cancer Institute
United States of America
Dr. Gao graduated from Beijing Second Medical College, China. After a brief residency he started his research career at the Beijing Lung Tumor Institute. From 1986-1990 he was a visiting research fellow in the South Western Medical Center in Dallas, Texas. He went on to become a Ph.D. scholar at the John Curtin School of Medical Research, Australian National University in Canberra, Australia and received his Ph.D. in human genetics in 1993. Dr. Gao is currently a senior scientist with Leidos Biomedical, Inc., and works in the Cancer and Inflammation Inflammation Program. His research interests are mainly focused on the genetic diversity of human populations and its impact on diseases, in particular, the polymorphism of MHC genes and its interaction with killer immunoglobulin-like receptors (KIR) genes.
human leukocyte antigen (HLA), major histocompatibility complex (MHC), killer cell immunoglobulin-like receptors (KIR)
Ranasinghe S, Cutler S, Davis I, Lu R, Soghoian DZ, Qi Y, Sidney J, Kranias G, Flanders MD, Lindqvist M, Kuhl B. Association of HLA-DRB1-restricted CD4+ T cell responses with HIV immune control. Nature medicine. 2013 Jul 1;19(7):930-3.
Bashirova AA, Martin-Gayo E, Jones DC, Qi Y, Apps R, Gao X, Burke PS, Taylor CJ, Rogich J, Wolinsky S, Bream JH. LILRB2 interaction with HLA class I correlates with control of HIV-1 infection. PLoS genetics. 2014 Mar 6;10(3):e1004196.
Salie M, van der Merwe L, Möller M, Daya M, van der Spuy GD, van Helden PD, Martin MP, Gao XJ, Warren RM, Carrington M, Hoal EG. Associations between human leukocyte antigen class I variants and the Mycobacterium tuberculosis subtypes causing disease. The Journal of infectious diseases. 2013 Aug 14;209(2):216-23.